Literature DB >> 4358402

Cyclic changes in levels of cyclic AMP and cyclic GMP in frog myocardium during the cardiac cycle.

A Wollenberger, E B Babskii, E G Krause, S Genz, D Blohm, E V Bogdanova.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4358402     DOI： 10.1016/0006-291x(73)91107-8

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  11 in total

1.  Lack of detectable change in cyclic AMP during the cardiac inotropic response to isoproterenol immobilized on glass beads.

Authors:  H C Venter; J Ross; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-03       Impact factor: 11.205

2.  Electrical and mechanical activity of mammalian heart fibres treated with papaverine. Interaction with isoprenaline and dibutyryl cyclic AMP.

Authors:  H Nawrath; T Meinertz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

3.  Relaxation of heart muscle by catecholamines and by dibutyryl cyclic adenosine 3',5'-monophosphate. Similarity of beta-adrenoceptors mediating contractile and relaxant effects of catecholamines in kitten pipillary muscle.

Authors:  A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-02       Impact factor: 3.000

4.  Transient changes in cyclic AMP and in the enzymic activity of protein kinase and phosphorylase during the cardiac cycle in the canine myocardium and the effect of propranolol.

Authors:  E G Krause; S Bartel; I Beyerdörfer; W Freier; K Gerber; D Obst
Journal:  Mol Cell Biochem       Date:  1989-09-07       Impact factor: 3.396

5.  Effects of RMI 12330A, a new inhibitor of adenylate cyclase on myocardial function and subcellular activity.

Authors:  G Grupp; I L Grupp; C L Johnson; M A Matlib; W Rouslin; A Schwartz; E T Wallick; T Wang; P Wisler
Journal:  Br J Pharmacol       Date:  1980-11       Impact factor: 8.739

6.  Cyclic nucleotide levels in the perfused rat heart subjected to hypoxia.

Authors:  R Nesher; W F Robinson; L Gibb; S P Bishop; F A Kruger
Journal:  Experientia       Date:  1977-02-15

7.  Negative inotropic effect of cyclic GMP in cardiac fiber fragments.

Authors:  W Trautwein; G Trube
Journal:  Pflugers Arch       Date:  1976-11-05       Impact factor: 3.657

8.  Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3':5'-cyclic monophosphate.

Authors:  J R Arch; E A Newsholme
Journal:  Biochem J       Date:  1976-09-15       Impact factor: 3.857

9.  Possible role of cyclic AMP in the relaxation process of mammalian heart: effects of dibutyryl cyclic AMP and theophylline on potassium contractures in cat papillary muscles.

Authors:  T Meinertz; H Nawrath; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-05       Impact factor: 3.000

10.  Carbachol and dibutyryl cyclic GMP on the vulnerability to ventricular fibrillation in rat isolated hearts.

Authors:  A Daugherty; B Woodward
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.